Gabelli & Co Investment Advisers’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-649,249	Closed	-$19.6M	–	194
2016 Q2	$19.6M	Buy	+649,249	New	+$13.2M	2.55%	6

Gabelli & Co Investment Advisers's CPXX Position: Q3 2016 in Review

Gabelli & Co Investment Advisers sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 649,249 shares — an estimated $19.6M sold.

Gabelli & Co Investment Advisers first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $19.6M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

Gabelli & Co Investment Advisers reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 649,249 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $19.6M.
Gabelli & Co Investment Advisers first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
Gabelli & Co Investment Advisers's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $19.6M in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2016, filed 14 Nov 2016.